RPRXRoyalty Pharma plc

$60.59

What is the market doing?

What the tape says about RPRX

Royalty Pharma plc is +71% over the past year while the S&P 500 is +20%: 51 points ahead of the market.

+71%

1-year return · S&P 500 +20%

vs 200-day average
+27%

vs 200-day average · a clear uptrend

RSI (14)
54

RSI (14) · neutral

Below its 52-week high
5.3%

Below its 52-week high

2024-08-15$23.46 – $63.98 · dashed line: 200-day average2026-09-08
Details
Last close2026-09-08
$60.59
1 monthS&P 500 −0.30%
+5.9%
1 yearS&P 500 +20%
+71%
5 yearsS&P 500 +85%
+86%
vs 50-day average$58.17
+4.2%
52-week high
$63.98
52-week low
$34.37
Annualised volatility
24%
Calendar-year price return
YearReturn
2026 (year to date)+58%
2025+55%
2024−6.4%
2023−27%
2022+0.99%
2021−19%
Average return by calendar month, 2020–2026
MonthYearsPositiveAverage
Jan64 of 6+4.4%
Feb63 of 6+2.7%
Mar63 of 6−1.7%
Apr64 of 6+1.5%
May62 of 6−0.88%
Jun63 of 6+0.35%
Jul75 of 7+0.86%
Aug73 of 7−0.78%
Sep71 of 7−3.3%
Oct63 of 6+0.47%
Nov65 of 6+5.0%
Dec63 of 6+0.60%

End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.